Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis
Open Access
- 1 January 1995
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (1) , 45-49
- https://doi.org/10.1128/aac.39.1.45
Abstract
We studied the effects of two antibiotic regimens on the course of Chlamydia pneumoniae infection in the lungs of Swiss Webster mice. After intranasal challenge with isolates AR-388 (1.3 x 10(7) inclusion-forming units per mouse) and AR-39 (1.5 x 10(6) inclusion-forming units per mouse), groups of animals were treated with either doxycycline (10 mg/kg of body weight once a day for 3 days), azithromycin (10 mg/kg [single dose]), or saline. Responses were assessed by the isolation of organisms in cell culture, detection of TWAR DNA in lung tissues by PCR, and lung histology. Both regimens were effective in clearing infections induced by AR-388 (P = 0.02 and 0.007 for doxycycline and azithromycin, respectively) compared with controls. TWAR DNA was detected in 77 and 25% of culture-negative lungs 2 weeks after treatment of AR-388 and AR-39 infections, respectively. Histological changes showed interstitial pneumonitis and were similar over time for all groups. Single-dose azithromycin produced drug levels in lung tissues above the MICs for the test strains for a period three times longer than that of single-dose doxycycline. We concluded that short-term antibiotic regimens were successful for the treatment of experimental TWAR pneumonitis in mice. TWAR DNA was frequently recovered from lung tissues after apparently successful treatment.Keywords
This publication has 41 references indexed in Scilit:
- Community-Acquired PneumoniaClinical Infectious Diseases, 1994
- AzithromycinDrugs, 1992
- Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachomaCurrent Eye Research, 1992
- Persistent Infection with Chlamydia pneumoniae following Acute Respiratory IllnessClinical Infectious Diseases, 1992
- Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- New and Emerging Etiologies for Community-Acquired Pneumonia with Implications for TherapyMedicine, 1990
- A Sensitive Cell Line, HL Cells, for Isolation and Propagation of Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990
- A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Importance of Reinfection in the Pathogenesis of TrachomaClinical Infectious Diseases, 1985